Investigating the cell permeability of proteolysis-targeting chimeras (PROTACs)

被引：13
|
作者：
Yokoo, Hidetomo [1 ,2 ]
Naito, Mikihiko [1 ,3 ,6 ]
Demizu, Yosuke [1 ,4 ,5 ,7 ]
机构：
[1] Natl Inst Hlth Sci, Div Organ Chem, Kawasaki, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Med Chem, Kyoto, Japan
[3] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Targeted Prot Degradat, Tokyo, Japan
[4] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Japan
[5] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Kita, Japan
[6] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Targeted Prot Degradat, Tokyo 1130033, Japan
[7] Natl Inst Hlth Sci, Div Organ Chem, 3-25-26 Tonomachi, Kawasaki, Kanagawa 2109501, Japan
来源：
EXPERT OPINION ON DRUG DISCOVERY | 2023年 / 18卷 / 04期
基金：
日本学术振兴会;
关键词：
Cell permeability; cell-penetrating peptide; molecular weight; nanoparticle; prodrug; PROTAC; SOLUBILITY; MOLECULES; DESIGN;
D O I：
10.1080/17460441.2023.2187047
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：357 / 361
页数：5
相关论文
共 50 条
  • [41] Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK)
    Zhang, Chengwei
    Han, Xiao-Ran
    Yang, Xiaobao
    Jiang, Biao
    Liu, Jing
    Xiong, Yue
    Jin, Jian
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 304 - 314
  • [42] Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
    He, Yonghan
    Khan, Sajid
    Huo, Zhiguang
    Lv, Dongwen
    Zhang, Xuan
    Liu, Xingui
    Yuan, Yaxia
    Hromas, Robert
    Xu, Mingjiang
    Zheng, Guangrong
    Zhou, Daohong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [43] Advances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery
    Xi, Jia-Yue
    Zhang, Ru-Yue
    Chen, Ke
    Yao, Lin
    Li, Mu-Qiong
    Jiang, Ru
    Li, Xiao-Ye
    Fan, Li
    BIOORGANIC CHEMISTRY, 2022, 125
  • [44] Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
    Satoshi Yamanaka
    Hirotake Furihata
    Yuta Yanagihara
    Akihito Taya
    Takato Nagasaka
    Mai Usui
    Koya Nagaoka
    Yuki Shoya
    Kohei Nishino
    Shuhei Yoshida
    Hidetaka Kosako
    Masaru Tanokura
    Takuya Miyakawa
    Yuuki Imai
    Norio Shibata
    Tatsuya Sawasaki
    Nature Communications, 14
  • [45] Design, Synthesis and Biological Evaluation of α-Synuclein Proteolysis-Targeting Chimeras
    Wen, Tianzhi
    Chen, Jian
    Zhang, Wenqian
    Pang, Jiyan
    MOLECULES, 2023, 28 (11):
  • [46] Photopharmacology of Proteolysis-Targeting Chimeras: A New Frontier for Drug Discovery
    Zeng, Shenxin
    Zhang, Hongjie
    Shen, Zhengrong
    Huang, Wenhai
    FRONTIERS IN CHEMISTRY, 2021, 9
  • [47] Advances in AR-targeting chimeras: a case study of proteolysis-targeting chimeras from bench to bedside
    Du, Wu
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (20) : 1471 - 1489
  • [48] Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein Degradation
    Ruffilli, Camilla
    Roth, Sascha
    Rodrigo, Monica
    Boyd, Helen
    Zelcer, Noam
    Moreau, Kevin
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2022, 5 (10) : 849 - 858
  • [49] Recent advances in epigenetic proteolysis targeting chimeras (Epi-PROTACs)
    Tomaselli, Daniela
    Mautone, Nicola
    Mai, Antonello
    Rotili, Dante
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 207
  • [50] Development of 2-Aminoadenine-Based Proteolysis-Targeting Chimeras (PROTACs) as Novel Potent Degraders of Monopolar Spindle 1 and Aurora Kinases
    Sflakidou, Eleni
    Adhikari, Bikash
    Siokatas, Christos
    Wolf, Elmar
    Sarli, Vasiliki
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (11) : 3488 - 3501
12345